Eyebot $20M Series A Sales Trigger

Pipeline boost: Eyebot secures $20M Series A. Pitch self-serve vision-test kiosks, streamline patient flow, close deals faster.

Published on


Do not index
Do not index

πŸš€ Battle Card: Eyebot

Quick trigger:
Β 
πŸ‘€ Decision Maker in the News
Β 
πŸ’‘ Why It Matters
  • Rapid, self-serve vision tests eliminate weeks-long waits and insurance hurdles for patients. This Eyebot sales trigger underscores the urgency of real-time, low-friction patient journeys. β†’ Source
Β 
🎯 Core Pain Point
  • Lengthy prescription turnaround keeps clinics overloaded and patients frustrated
  • High cost & insurance dependency blocks access for uninsured or underinsured patients
Β 
πŸ’° What to Pitch
  • Primary: Self-serve rapid vision-testing kiosks β†’ Deliver doctor-verified prescriptions in under 2 minutes
  • Expansion: Clinic management integration β†’ Streamline patient throughput and boost margins
Β 
πŸ—ΊοΈ Quick Context
  • HQ: Boston, MA / USA
  • Employees: β‰ˆ 30
  • Rev: β‰ˆ $1M
Β 

🀼 Competitive Intel

Which other vendors you’ll probably face to win Eyebot’s business.
Β 
  • Topcon Medical β€” Vision testing kiosks / diagnostic devices
    • Unique edge: Established brand in ophthalmic hardware
    • Evaluated by clinic directors for device durability
  • Nidek β€” Automated refractors / diagnostic devices
    • Unique edge: Precision optics with global support
    • Evaluated by COO & IT for integration ease
  • ZEISS β€” Ophthalmic diagnostic solutions
    • Unique edge: High-accuracy patented technology
    • Evaluated by VPs of Ops for quality assurance
  • EssilorLuxottica β€” Lens crafting & testing solutions
    • Unique edge: Vertical integration from lens to testing
    • Evaluated by CFO for total cost of ownership
Β 

βœ… Do-Now Checklist

Connect with all decision makers on LinkedIn (links above)
Generate email + DM with the Copy-My-Prompt block (Step 7) and send first touch
Leverage the Eyebot sales trigger in your outreach subject lines
Β 

Next Step

Get more Eyebot sales trigger intel like this dailyβ€”no fluff, all pipeline. Subscribe to NewsletterForLeads
Β 

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑❑
OFFER_BRIEF   = ❑Self-serve rapid vision-testing kiosks deliver doctor-verified prescriptions in under 2 minutes❑
PROOF_METRIC  = ❑90-second vision tests verified by licensed doctors❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
πŸ“Œ TARGET COMPANY
────────────────────────────
NAME        = Matthias
COMPANY     = Eyebot
DEPT        = β‰ˆ TBD
SIZE        = β‰ˆ 30
BOTTLENECK  = lengthy prescription turnaround
EVENT       = $20M Series A financing
DETAIL      = $20M Series A financing
PAIN        = long waits for prescriptions frustrate patients
SRC         = https://vcnewsdaily.com/eyebot/venture-capital-funding/xmkypcqsvw
SIM_CO      = β‰ˆ TBD
WIN_METRIC  = β‰ˆ TBD
NEXT_SIZE   = β‰ˆ TBD
EMP_EST     = β‰ˆ 30
REV_EST     = β‰ˆ $1M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: β€œNewsletterForLeads SDR-Assist”.

Validate any β‰ˆ guesses via SRC.

EMAIL  (keep breaks):
Subject: β‰ˆ 30-person β‰ˆ TBD

Matthiasβ€”noticed your β‰ˆ TBD team is β‰ˆ 30.

That’s when lengthy prescription turnaround slows growth.

We helped β‰ˆ TBD fix this with Self-serve rapid vision-testing kiosks deliver doctor-verified prescriptions in under 2 minutes.

Result: β‰ˆ TBD.  
Quick call?

PSβ€”next bottleneck hits β‰ˆ TBD.

DM ≀45 words, TONE:
Saw your post about $20M Series A financing β€” long waits for prescriptions frustrate patients.  
Self-serve rapid vision-testing kiosks deliver doctor-verified prescriptions in under 2 minutes. 90-second vision tests verified by licensed doctors.  
Quick chat?

Join other 3200+ marketers now!

Ready to take the next big step for your business?

Subscribe